At a glance
- Originator Johnson & Johnson Pharmaceutical Research & Development
- Developer Johnson & Johnson Pharmaceutical Research & Development LLC
- Class Antidiarrhoeals
- Mechanism of Action Opioid delta receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diarrhoea
Most Recent Events
- 25 Sep 2006 Discontinued - Preclinical for Diarrhoea in USA (unspecified route)
- 28 Jan 2003 Data presented at the 32nd annual meeting of the Society for Neuroscience (SFN) has been added to the Digestive System Disorders pharmacodynamics section
- 22 Dec 2002 Preclinical trials in Diarrhoea in USA (unspecified route)